Fujifilm India Private Limited, a pioneer in imaging technologies has recently joined hands with Bengaluru-based Sakra World Hospital, a leading multispecialty hospital to assist doctors in diagnosing the possibility of COVID-19 pneumonia among patients with the help of a new AI-enabled software.
This association has been borne out of Fujifilm India’s campaign “COVID-19 Pneumonia Image Analysis Program” which helps in diagnosing chest CT images by offering characteristic image findings of COVID-19 pneumonia across three stages.
As the Covid-19 pneumonia wreaked havoc in India and affected several families in the country, the Covid-AI-enabled software “COVID-19 Pneumonia Image Analysis Program” by Fujifilm India is a software that has strengthened India’s fight towards Covid-19. The technology automatically analyses the chest CT images and displays the results which assists doctors in diagnosing COVID-19 pneumonia and ultimately saving human lives.
Additionally, SYNAPSE 3D, a workstation system visualizes and analyzes high-precision 3D images from tomographic images such as CT and MRI by utilizing Fujifilm India’s image recognition technology.
As we know the spread of the new Coronavirus infection has been overwhelming in hospitals, hence, for better diagnosis of the occurrence of COVID-19 among patients post-Covid, chest CT is conducted in addition to PCR/Antigen tests at the time of hospitalization or in emergency situations.
While the burden of these tests is increasing, there is a dire need for solutions that support efficient tests and accurate diagnostic imaging, especially for the patients with post COVID lung management issues.
Fujifilm India has always contributed and will continue to contribute to making health conditions better in India and ensuring a good lifestyle for its citizens. Our vision is to develop technology and create innovative products that leads all of mankind to a healthier and sustainable existence.
Bangalore, 20th October 2021
.JPG)
